|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2020
Distler, F. A.; Pahernik, S.; Gakis, G.; Hutterer, G.; Lebentrau, S.; Rink, M.; Nuhn, P.; Brookman-May, S.; Burger, M.; Gratzke, C.; Wolff, I. und May, M.
(2020):
Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey.
In: World Journal of Urology, Bd. 38, Nr. 10: S. 2523-2530
2017
May, M.; Protzel, C.; Vetterlein, M. W.; Gierth, M.; Noldus, J.; Karl, A.; Grimm, T.; Wullich, B.; Grimm, M. O.; Nuhn, P.; Bastian, P. J.; Roigas, J.; Hadaschik, B.; Gilfrich, C.; Burger, M.; Fisch, M.; Brookman-May, S.; Aziz, A. und Hakenberg, O. W.
(2017):
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
In: International Urology and Nephrology, Bd. 49, Nr. 2: S. 247-254
2016
Weidenbusch, M.; Rodler, S.; Song, S.; Seliger, B.; Ritter, M.; Stief, C.; Anders, H.-J. und Nuhn, P.
(2016):
Interleukin-22, a T cell secreted cytokine, contributes to renal cell carcinoma progression and is associated with poor outcome in RCC patients.
In: Oncology Research and Treatment, Bd. 39: S. 171